| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.4B | $13.0B | $12.4B | $12.3B | $9.6B | $2.6B | $2.5B | $2.7B |
| Cost of Revenue | $8.6B | $8.5B | $8.1B | $7.6B | $6.5B | $6.2B | $6.0B | $6.1B |
| Gross Profit | $4.8B | $4.5B | $4.3B | $4.7B | $3.1B | $0.7B | $0.7B | $0.8B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.3B | $3.2B | $2.8B | $2.7B | $2.3B | $2.2B | $2.0B | $2.0B |
| Operating Income | $1.5B | $1.3B | $1.5B | $2.0B | $0.7B | $0.1B | $0.1B | $0.2B |
| Net Income | — | — | — | — | — | — | — | — |
| EPS (Basic) | $14.48 | $12.72 | $13.43 | $18.27 | $6.29 | $0.83 | $1.09 | $1.11 |
| EPS (Diluted) | $14.05 | $12.18 | $10.78 | $13.87 | $5.72 | $0.81 | $1.07 | $1.11 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.5B | $9.3B | $9.0B | $9.0B | $7.8B | $6.6B | $4.2B | $4.2B |
| Current Assets | $5.4B | $4.9B | $5.0B | $5.1B | $3.8B | $2.4B | $2.1B | $2.0B |
| Cash & Equivalents | $1.7B | $1.8B | $1.9B | $2.6B | $1.7B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.1B | $2.8B | $2.6B | $2.7B | $2.6B | $2.1B | $1.5B | $1.4B |
| Stockholders' Equity | $3.2B | $2.6B | $2.5B | $2.1B | $2.3B | $1.7B | $1.9B | $1.9B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $1.5B | $0.9B | $1.6B | $1.6B | $0.4B | — | — |
| Investing Cash Flow | $-0.8B | $-0.6B | $-0.4B | $-0.3B | $-0.2B | $-0.1B | — | — |
| Capital Expenditures | $0.8B | $0.6B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B | $0.5B |
| Financing Cash Flow | $-0.6B | $-1.0B | $-1.2B | $-0.3B | $0.3B | $-0.3B | — | — |